Advisory Research Inc Cyma Bay Therapeutics, Inc. Transaction History

Advisory Research Inc

  • $548 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$12.63 - $24.47 $70,159 - $135,930
-5,555 Reduced 5.31%
98,985 $2.34 Million
Q3 2023

Nov 13, 2023
SELL
$10.86 - $17.62 $192,145 - $311,750
-17,693 Reduced 14.47%
104,540 $1.56 Million
Q2 2023

Aug 14, 2023
BUY
$7.47 - $10.95 $913,080 - $1.34 Million
122,233 New
122,233 $1.34 Million

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email